Sponsored by

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1 to 25 of about 5545

Website Changes

03/31/2023

Recombinant polio–rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial

03/28/2023

Apogenix’ Partner CANbridge Announces 67 % Five-Year Overall Survival Rate Compared to 8.2 % in Institutional Database With Asunercept Plus Standard of Care in Newly Diagnosed Glioblastoma Multiforme

03/28/2023

Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5

03/24/2023

The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models

03/17/2023

FDA Approves Dabrafenib Plus Trametinib for Pediatric BRAF V600E-Mutant Low-Grade Glioma

03/15/2023

Servier`s Pivotal Phase 3 INDIGO Trial Investigating vorasidenib in IDH-Mutant Low-Grade Glioma Meets Primary Endpoint of Progression-Free Survival (PFS) and Key Secondary Endpoint of Time to Next Intervention (TTNI)

03/15/2023

Drug offers renewed hope to brain cancer patients

03/15/2023

Hoops For Hannah Brackets Deadline

03/13/2023

Head to the Hill 2023

03/12/2023

Newly-diagnosed high grade glioma surgery with carmustine wafers implantation. A long-term nationwide retrospective study

03/12/2023

Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas

03/08/2023

Novocure Announces Reimbursement of Optune® for the Treatment of Newly Diagnosed Glioblastoma in France

03/08/2023

Weil Cornell Medicine webinars on Advances in Brain Tumor Research and Treatments

03/07/2023

Learnings from Pilot Study: Creating Treatment Templates to Serve More Glioblastoma Patients

03/06/2023

Foundation stirs controversy by charging cancer patients $83,000 for unproven but promising experimental drug

03/06/2023

Musella Foundation Copay Program now open to new and renewal patients!

02/10/2023

A Critical Analysis of Neuro-Oncology Clinical Trials

02/10/2023

Immunotoxin-aCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models

02/08/2023

Dose-dependent efficacy of bevacizumab in recurrent glioblastoma

02/08/2023

Musella Foundation Copay Program now closed to new and renewal patients

02/03/2023

OKN-007 Expanded Access for Pediatric Patients with Diffuse Midline Glioma(including DIPG)

01/15/2023

Targeting the IL4 Receptor with MDNA55 in Patients with Recurrent Glioblastoma: Results of a Phase 2b Trial

01/15/2023

Drug Against Most Common Pediatric Brain Cancer Achieves Trial Success

01/14/2023

Feinstein Institutes, Northwell Use Ultrasound to Treat Brain Tumors in Novel Clinical Trial

01/14/2023

New drug combination may effectively treat often fatal childhood brain tumor

Our privacy / cookie policy has changed.
Click HERE to read it!